3rd Quarter - Report

JOHNS HOPKINS UNIVERSITY for JOHNS HOPKINS UNIVERSITY

Firm
Client
Income
—
Expenses
$90,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Graduate medical education funding; Recovery audit contractors

LobbyistCovered position, as disclosed
BETH ANN FELDER —
MELISA LINDAMOOD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

FY16 appropriations; NIH funding for biomedical research

LobbyistCovered position, as disclosed
BETH ANN FELDER —
JEFFREY GROSSI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Education EDU

Elementary and Secondary Education Act

LobbyistCovered position, as disclosed
JEFFREY GROSSI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Pharmaceutical drug price increases; 340B drug discount program

LobbyistCovered position, as disclosed
MELISA LINDAMOOD —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Science/Technology SCI

Biomedical research and innovation, H.R.6 21st Century Cures Act; Intellectual property and tech transfer, H.R. 9 Innovation Act

LobbyistCovered position, as disclosed
BETH ANN FELDER —
JEFFREY GROSSI —
MELISA LINDAMOOD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th), H.R. 9 (114th)

Health Issues HCR

Humane cosmetics; Technical changes to Stark law; Medical device interoperability and meaningful use; Lyme disease

LobbyistCovered position, as disclosed
MELISA LINDAMOOD —
DAVID PARKER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.